Physician profile
Adan Mora
NPI 1376730549
$1,256.97
in general payments reported to CMS, 2019-2025
13 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $17.58 · 2022: $140 · 2023: $81.20 · 2024: $251 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $348.19 | 2023-2025 | |
| La Jolla Pharmaceutical Company | $233.70 | 2019-2022 | |
| Cook Medical LLC | $166.56 | 2019 | |
| Novo Nordisk INC | $146.24 | 2019 | |
| Gilead Sciences, INC. | $132.24 | 2024 | |
| Medivance, INC. | $121.76 | 2019 | |
| Haemonetics Corporation | $27.09 | 2022 | |
| Mallinckrodt Enterprises LLC | $20.23 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $18.75 | 2019 | |
| Acera Surgical, INC. | $17.58 | 2020 | |
| Kci USA, INC. | $12.39 | 2019 | |
| Merck Sharp & Dohme LLC | $12.24 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adan Mora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.